🔎 Trials Near Me

Home › Colon Cancer › North Carolina

Pag-aaral pangklinika para sa Colon Cancer sa North Carolina

20 pag-aaral para sa Colon Cancer ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

Family Communications After Genetic Testing

  • Southeastern Medical Oncology Center-Clinton, Clinton
  • CaroMont Regional Medical Center, Gastonia
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro
  • at 2 pa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07143487

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07283939

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Novant Health Cancer Institute - Kernersville, Kernersville
  • Novant Health Cancer Institute - Mount Airy, Mount Airy
  • Novant Health Forsyth Medical Center, Winston-Salem
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  • WakeMed Raleigh Campus ( Site 0094), Raleigh
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06997497

A Study of PHN-012 in Patients With Advanced Solid Tumors

  • PHN-012-001 Site, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Duke Cancer Center Cary, Cary
  • Duke Cancer Center - Investigational Chemotherapy Service, Durham
  • Duke Cancer Center, Durham
  • at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

  • Messino Cancer Center, Asheville
  • The University of North Carolina At Chapel Hill, Chapel Hill
  • Oncology Specialists of Charlotte, Charlotte
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07284849

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • UNC- Chapel Hill, Chapel Hill
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

  • Southeastern Medical Oncology Center-Clinton, Clinton
  • Southeastern Medical Oncology Center-Goldsboro, Goldsboro
  • Southeastern Medical Oncology Center-Jacksonville, Jacksonville
Nagre-recruit
Edad 45 hanggang 70 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

  • Duke Cancer Center Cary, Cary
  • UNC Health Cancer Care Cary, Cary
  • Waverly Hematology Oncology, Cary
  • at 22 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05174169

Shield Post-Approval Study Protocol

  • Cary Gastroenterology Associates, Cary
  • University of North Carolina at Chapel Hill, Chapel Hill
  • University of North Carolina at Chapel Hill, Chapel Hill
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 81 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06880055

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

  • Xencor Investigative Site, Charlotte
  • Xencor Investigative Site, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05433142

Integrated Cancer Repository for Cancer Research

  • Cape Fear Valley Health System, Fayetteville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

  • Research Site, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

  • Duke Cancer Center, Durham
  • Carolina BioOncology Institute, Huntersville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  • GSK Investigational Site, Durham
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT05855200

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Chapel Hill
  • Massive Bio SYNERGY-AI site, Winston-Salem
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

  • Virtual Research Group, Morrisville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT06864338

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  • University of North Carolina, Chapel Hill
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 27, 2025 · NCT03175224

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.